Alcon Inc. (ALC)

USD 98.3

(2.21%)

Operating Income Summary of Alcon Inc.

  • Alcon Inc.'s latest annual operating income in 2023 was 1.03 Billion USD , up 87.58% from previous year.
  • Alcon Inc.'s latest quarterly operating income in 2024 Q2 was 327.97 Million USD , down -13.59% from previous quarter.
  • Alcon Inc. reported an annual operating income of 672 Million USD in 2022, up 15.86% from previous year.
  • Alcon Inc. reported an annual operating income of 580 Million USD in 2021, up 220.33% from previous year.
  • Alcon Inc. reported a quarterly operating income of 368 Million USD for 2024 Q1, down -18.98% from previous quarter.
  • Alcon Inc. reported a quarterly operating income of 270 Million USD for 2023 Q2, up 0.75% from previous quarter.

Annual Operating Income Chart of Alcon Inc. (2023 - 2015)

Historical Annual Operating Income of Alcon Inc. (2023 - 2015)

Year Operating Income Operating Income Growth
2023 1.03 Billion USD 87.58%
2022 672 Million USD 15.86%
2021 580 Million USD 220.33%
2020 -482 Million USD -157.75%
2019 -187 Million USD 24.6%
2018 -248 Million USD -222.08%
2017 -77 Million USD -870.0%
2016 10 Million USD -97.51%
2015 401.11 Million USD 0.0%

Peer Operating Income Comparison of Alcon Inc.

Name Operating Income Operating Income Difference
AptarGroup, Inc. 404.01 Million USD -157.166%
Baxter International Inc. 390 Million USD -166.41%
Becton, Dickinson and Company 2.42 Billion USD 57.155%
Bausch + Lomb Corporation 130 Million USD -699.231%
Haemonetics Corporation 164.88 Million USD -530.144%
Envista Holdings Corp 31.5 Million USD -3198.413%
ResMed Inc. 1.31 Billion USD 21.281%
Teleflex Incorporated 506.31 Million USD -105.209%
Warby Parker Inc. -71.99 Million USD 1543.136%
West Pharmaceutical Services, Inc. 676 Million USD -53.698%